Trxade Group Inc (MEDS)

Name: Trxade Group Inc (MEDS) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Trxade Group Inc (MEDS)

Stock Card

$1.17

$-0.17 (-12.36%)

As on 27-Aug-2026 16:25EDT

Market cap

$4 Mln

Revenue (TTM)

$8 Mln

P/E Ratio

P/B Ratio

1.8

Div. Yield

0 %

Trxade Group Inc (MEDS) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 1.16 High: 1.28

52 Week Range

Low: 1.16 High: 1.57

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

0 %
ROCE

-- %
Industry P/E

21.88
EV/EBITDA

0
Debt to Equity

0
Book Value

$--
EPS

$-55.3
Face value

--
Shares outstanding

3,061,919

10 Years Aggregate

CFO

$-11.37 Mln

EBITDA

$-17.33 Mln

Net Profit

$-34.83 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Trxade Group Inc (MEDS)	--	--	--	--	-44.7	-56.3	-32.9
BSE Sensex	-9.1	1.1	1.2	-4.8	5.8	6.6	10.7
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 27-Aug-2026 | #As on 26-Oct-2023

Company	2023	2022	2021	2020	2017
Trxade Group Inc (MEDS)	-14.0	-82.9	-55.4	-19.8	-2.2
S&P Small-Cap 600	13.9	-17.4	25.3	9.6	11.7
BSE Sensex	18.7	4.4	22.0	15.8	27.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About Trxade Group Inc (MEDS)

DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for... consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierge services, . The company was formerly known as Wellgistics Health, Inc. and changed its name to DataMEDS AI, Inc. in July 2026. DataMEDS AI, Inc. was incorporated in 2022 and is based in Tampa, Florida. Read more

Founder, Chairman, CEO & Secretary

Mr. Surendra K. Ajjarapu
Founder, Chairman, CEO & Secretary

Mr. Surendra K. Ajjarapu
Headquarters

Tampa, FL
Website

https://datamedsai.com

FAQs for Trxade Group Inc (MEDS)

What is the current share price of Trxade Group Inc (MEDS) Today?

The share price of Trxade Group Inc (MEDS) is $1.17 (NASDAQ) as of 27-Aug-2026 16:25 EDT. Trxade Group Inc (MEDS) has given a return of -44.73% in the last 3 years.

What is the current PB & PE ratio of Trxade Group Inc (MEDS)?

Since, TTM earnings of Trxade Group Inc (MEDS) is negative, P/E ratio is not available.
The P/B ratio of Trxade Group Inc (MEDS) is 1.81 times as on 21-Aug-2026, a 66 discount to its peers’ median range of 5.32 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	--	--
2024	--	--
2023	-1.68	-1.68
2022	--	--
2021	--	--

What is the 52 Week High and Low of Trxade Group Inc (MEDS)?

The 52-week high and low of Trxade Group Inc (MEDS) are Rs 1.57 and Rs 1.16 as of 28-Aug-2026.

What is the market cap of Trxade Group Inc (MEDS)?

Trxade Group Inc (MEDS) has a market capitalisation of $ 4 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Trxade Group Inc (MEDS)?

Before investing in Trxade Group Inc (MEDS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.